Cipla poised to maintain high growth, earnings may grow by ove...Growth is expected to be strong in the March 2017-18 quarter (Q4) as well and in the current financial year Ujjval Jauhari | New Delhi Last Updated at April 25, 2018 03:12 IST An employee works at the reception area of Cipla at its headquarters in Mumbai | ... Business Standard, 1 day ago |
56 images for cipla | ||||
USFDA conducts inspection at Cipla#39;s Indore facility"The United States Food and Drug Administration (USFDA) conducted a routine current Good Manufacturing Practices (cGMP) audit at its Indore formulations facility from April 2, 2018 till April 13, 2018," Cipla said in a BSE filing. Money Control, 1 week ago
Cipla gains 4% after USFDA inspection with no data integrity or repeat observations
Money Control, 1 week ago
Cipla gains 5% after USFDA inspection with no data integrity or repeat observations
Money Control, 1 week ago
|
Indiabulls Ventures Ltd leads gainers in 'A' groupGRUH Finance Ltd, Cipla Ltd, Ujjivan Financial Services Ltd and Grasim Industries Ltd are among the other gainers in the BSE's 'A' group today, 16 April 2018. Indiabulls Ventures Ltd soared 13.17% to Rs 359.25 at 11:53 IST. The stock was the biggest gainer in ... Business Standard, 1 week ago
Cipla Ltd down for fifth straight session
Business Standard, 2 weeks ago
Cipla Ltd rose for a third straight session today
Business Standard, 2 months ago
|
Market Update: Sensex, Nifty rebound as realty stocks outperform; HDFC Bank up 1%; Cipla top Nifty gainerThe top Nifty gainers included Cipla which was jumped 4 percent while Grasim Industries gained 2.5 percent. Hero MotoCorp and Indiabulls Housing Finance along with Kotak Mahindra Bank were the other gainers. Money Control, 1 week ago
Market Live: Sensex extends gains to almost 200 points, Nifty holds 10,150; banks recover
Money Control, 3 weeks ago
Market Update: ICICI Bank falls over 2%, drags Bank Nifty lower; Ashok Leyland hits new 52-week high
Money Control, 1 month ago
|
Market Update: Nifty Pharma gains led by Cipla, Divi#39;s Labs; Zee Entertainment up 2%, DHFL most activeThe market breadth was in favour of the advances with 900 stocks advancing while 658 declined and 471 remained unchanged. On the other hand, in the BSE, 988 stocks advanced and 705 declined and 89 remained unchanged. Money Control, 1 week ago
Market Update: Cipla, Lupin jump 5% as CNX Pharma gains 2%; Avenue Supermarts hits new 52-week high, ICICI most active
Money Control, 3 weeks ago
|
Cipla arm recalls multiple lots of antidepressant drug from US marketThe report, however, did not mention the quantity of the product Last Updated at April 15, 2018 12:18 IST An employee works at the reception area of Cipla at its headquarters in Mumbai Pharma major Cipla's arm InvaGen Pharmaceuticals Inc is recalling 11 lots ... Business Standard, 1 week ago
|
OTC biz to contribute 15-20% to revenuesAnkit Bhembre & Karthikeyan Thangarajan(Analysts, Ind-Ra) We expect Indian formulators to continue to make investments to grow their domestic non-prescription business through organic and inorganic routes. It would be driven by the need to further diversify ... The Financial Chronicle, 2 days ago
|
Key equity indices trade lower following global cuesMumbai : The key Indian equity markets traded marginally lower on Monday afternoon weighed on by heightened geo-political tensions in the Middle East, along with broadly negative cues from the Asian markets. Healthy buying in healthcare and fast moving ... Sify, 1 week ago
Unchanged Repo Rates; Key Earnings Report and Other Top Cues to Sway Markets Today
Equitymaster.com, 2 months ago
|
Closing Bell: Sensex ends 74 pts higher but fails to hold 33K; Bharti Infratel up 5%Cipla recovered from day#39;s low after the company clarified saying certain observations issued by the USFDA during product specific pre-approval inspection of Goa unit are procedural in nature. Money Control, 1 month ago
Cipla gets USFDA observations for its Goa plant
Money Control, 1 month ago
Cipla shares trim losses after company clarifies on USFDA observations for Goa unit
Money Control, 1 month ago
Cipla shares drop 7% on USFDA observations for Goa unit
Money Control, 1 month ago
|
Cipla teams up with Roche Pharma to sell cancer therapy drugs in IndiaDrug firm Cipla and Roche Pharma India has said that they have entered an agreement under which Cipla will promote and distribute tocilizumab and Syndyma, the 2nd brand of Roche's cancer therapy bevacizumab in India.This partnership is in line with Cipla and ... Business Standard, 1 month ago
Cipla gains 1% on partnership with Roche Pharma
Money Control, 1 month ago
Cipla, Roche turn partners for the first time to sell cancer drugs
Business Standard, 1 month ago
Indian pharma firms renew focus; Dr Reddy's, Cipla eye $100-bn China market
Business Standard, 2 months ago
|